Promising immunotherapy helps adults with leukemia – Inquirer.net
Inquirer.net |
Promising immunotherapy helps adults with leukemia
Inquirer.net MIAMI—A cancer treatment that genetically alters immune cells has shown success in 71 percent of adults with the most common form of leukemia, and for whom other medicines had failed, US researchers said Monday. The treatment, known as experimental … |
|
Global Market Study on Allergic Rhinitis Treatment: Immunotherapy Treatment Segment Projected to be the Fastest …
PR Newswire (press release) LONDON, July 17, 2017 /PRNewswire/ — Persistence Market Research in its recent report “Allergic Rhinitis Treatment Market: 2016–2024,” examines the global allergic rhinitis treatment market for the period of eight years. i.e. 2016-2024. The primary … |
Capitol Weekly |
LAT: ‘Secret Life’ of former USC Med School dean, stem cell agency director
Capitol Weekly He still serves, as a gubernatorial appointee, on the board of the California Institute for Regenerative Medicine (CIRM), as the stem cell agency is formally known. The board position pays $100 a day for meeting attendance. The board meets 10 to 12 … An overdose, a young companion, drug-fueled parties: The secret life of USC med school deanLos Angeles Times |
NewCo Shift |
The Future of Augmented Reality Ain’t Pokemon Go
NewCo Shift I figured this would also let me stuff my book full of 20-page digressions on how cooooool AR, synthetic biology, quantum computing, and other fields are (or rather, will be. You know — nine seconds from now). As it turns out, 20-page digressions … |
Daily Mail |
Would YOU try it? The bandage made from your own stem cells that can actually fix a dodgy knee
Daily Mail This involved cutting a 3cm square of the stem cell patch and placing it around the torn meniscus via a small incision on his knee. The idea was that the stem cells would grow into new cartilage and repair the tear — a process that would take about 13 … |
|
CAR T-cell therapy for leukemia leads to remissions in clinical trial
EurekAlert (press release) “It was not known whether CAR T-cells could be used to treat these high risk CLL patients,” said lead author Dr. Cameron Turtle, an immunotherapy researcher at Fred Hutch. “Our study shows that CD19 CAR T-cells are a highly promising treatment for CLL … |